The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling.
2018-10-12

2018. Hur J, Kang JY, Rhee CK, Kim YK, Lee SY. Pulmonary Pharmacology & Therapeutics 48: 5-14.